What is Biogen's license — contract with customer, liability?

Biogen (BIIB) reported license — contract with customer, liability of $103.00M in Q2 2024.

What does license — contract with customer, liability mean?

The value of licensing services or rights owed to customers for which payment has already been received.

Discontinued — last reported Q2 '24

Products & Services · Contract with customer, liability

License — Contract with customer, liability

Analysis

StatementSegment

CategoryLiquidity

SignalContext dependent

VolatilityModerate

First reportedQ2 2024

Last reportedQ2 2024

Rolls up toContract Liabilities

How to read this metric

An increase indicates strong upfront demand for licensing rights, while a decrease suggests that the company is successfully fulfilling its performance obligations and recognizing the associated revenue.

Detailed definition

This metric represents the deferred revenue or contractual obligations recognized as a liability arising from licensing...

Peer comparison

Comparable to 'Deferred revenue' or 'Contract liabilities' related to licensing and collaboration agreements reported by other life sciences firms under ASC 606.

Metric ID: biib_segment_license_contract_with_customer_liability

Historical Data

1 periods

	Q2 '24
Value	$103.00M

Similar Metrics at Other Companies

Estee Lauder Companies Inc.EL View metric

Natera, Inc.NTRA View metric

Estee Lauder Companies Inc.EL View metric

Frequently Asked Questions

What is Biogen's license — contract with customer, liability?: Biogen (BIIB) reported license — contract with customer, liability of $103.00M in Q2 2024.
What does license — contract with customer, liability mean?: The value of licensing services or rights owed to customers for which payment has already been received.